Therefore, there is certainly evidence that the vaccines pose a risk which the unvaccinated don’t face. The only question is the scale of that risk. But unless the regulators actually investigate those risks, it will remain completely unknown. As long as it remains unknown, there is no justification to any claim that the benefits of the vaccines outweigh the risks. It is untenable.

The Norwegian health authorities did undertake a risk assessment. Their data showed that the risks from the AstraZeneca vaccine outweighed the risk of Covid-19 for Norwegians under 65. They halted the use of the Vaxzevria (AZD1222 brand name) vaccine.

Read the article on UK Column